The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation

被引:47
作者
Sakata, Y
Koibuchi, N
Xiang, F
Youngblood, JM
Kamei, CN
Chin, MT
机构
[1] Brigham & Womens Hosp, Cambridge, MA 02139 USA
[2] Harvard Univ, Sch Med, Cambridge, MA 02139 USA
关键词
cardiovascular development; ventricular septal defect; cardiomyopathy; tricuspid valve stenosis; knockout mouse; bHLH transcription factor; CHF1/Hey2; vascular development; mitral valve disorder;
D O I
10.1016/j.yjmcc.2005.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CHF1/Hey2 null mice generated in different laboratories have discrepant cardiovascular phenotypes. To determine the effect of genetic background on phenotype, we backcrossed Our knockout strain more than eight generations to the inbred strains BALB/c and C57BL/6. Knockout mice on these backgrounds showed disparate phenotypes. Mice on both backgrounds demonstrated ventricular septal defects (VSDs), tricuspid stenosis and mitral valve thickening, but at varying frequencies, suggesting a general defect in endocardial Cushion remodeling. Additional defects seen exclusively on the C57BL/6 background included biventricular wall thinning and left ventricular enlargement, implying a more severe myocardial defect than previously observed. In addition, aortas and pulmonary arteries from these null mice had thinner walls. Intercrossing of the CHF1/Hey2 null mice on a C57BL/6 background with a C57BL/6 MLC2v-CHF1/Hey2 transgenic line overexpressing CHF1/Hey2 in the atrial and ventricular myocardium also rescued the VSD and myocardial phenotypes, but did not affect vascular wall thickness. Our results indicate that CHF1/Hey2 provides an important myocardial signal to the endocardial cushion for proper septation and valve formation and also plays in important role in maturation of the myocardium and vasculature. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 35 条
[1]   THE CLINICAL AND GENETIC SPECTRUM OF THE HOLT-ORAM SYNDROME (HEART-HAND SYNDROME) [J].
BASSON, CT ;
COWLEY, GS ;
SOLOMON, SD ;
WEISSMAN, B ;
POZNANSKI, AK ;
TRAILL, TA ;
SEIDMAN, JG ;
SEIDMAN, CE .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) :885-891
[2]   Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways [J].
Benson, DW ;
Silberbach, GM ;
Kavanaugh-McHugh, A ;
Cottrill, C ;
Zhang, YZ ;
Riggs, S ;
Smalls, O ;
Johnson, MC ;
Watson, MS ;
Seidman, JG ;
Seidman, CE ;
Plowden, J ;
Kugler, JD .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (11) :1567-1573
[3]   Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome [J].
Bruneau, BG ;
Logan, M ;
Davis, N ;
Levi, T ;
Tabin, CJ ;
Seidman, JG ;
Seidman, CE .
DEVELOPMENTAL BIOLOGY, 1999, 211 (01) :100-108
[4]   Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells - Implications in cell-cycle regulation [J].
Campos, AH ;
Wang, WL ;
Pollman, MJ ;
Gibbons, GH .
CIRCULATION RESEARCH, 2002, 91 (11) :999-1006
[5]   Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system [J].
Chin, MT ;
Maemura, K ;
Fukumoto, S ;
Jain, MK ;
Layne, MD ;
Watanabe, M ;
Hsieh, CM ;
Lee, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) :6381-6387
[6]   Genetic background determines the extent of atherosclerosis in ApoE-deficient mice [J].
Dansky, HM ;
Charlton, SA ;
Sikes, JL ;
Heath, SC ;
Simantov, R ;
Levin, LF ;
Shu, P ;
Moore, KJ ;
Breslow, JL ;
Smith, JD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) :1960-1968
[7]   Tetralogy of Fallot and other congenital heart defects in Hey2 mutant mice [J].
Donovan, J ;
Kordylewska, A ;
Jan, YN ;
Utset, MF .
CURRENT BIOLOGY, 2002, 12 (18) :1605-1610
[8]   The Notch target genes Hey1 and Hey2 are required for embryonic vascular development [J].
Fischer, A ;
Schumacher, N ;
Maier, M ;
Sendtner, M ;
Gessler, M .
GENES & DEVELOPMENT, 2004, 18 (08) :901-911
[9]   Hey genes in cardiovascular development [J].
Fischer, A ;
Gessler, M .
TRENDS IN CARDIOVASCULAR MEDICINE, 2003, 13 (06) :221-226
[10]  
Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt